← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2023-02-01

Drug application

FDA Application #

ANDA217029

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN SULFATE

Generic name

TOBRAMYCIN

Active ingredients

TOBRAMYCIN SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SLATE RUN PHARMA

Manufacturer

Slate Run Pharmaceuticals, LLC

First approval

2023-02-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown